ORAL IRON CHELATING DRUGS - COMING BUT NOT YET READY FOR CLINICAL USE

被引：24

作者：

HERSHKO, C

机构：

来源：

BRITISH MEDICAL JOURNAL | 1988年 / 296卷 / 6629期

关键词：

D O I：

10.1136/bmj.296.6629.1081

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1081 / 1082

页数：2

共 17 条

[11]

MARCUS RE, 1984, LANCET, V2, P392

[12] SURVIVAL AND DESFERRIOXAMINE IN THALASSEMIA MAJOR [J].

MODELL, B ;

LETSKY, EA ;

FLYNN, DM ;

PETO, R ;

WEATHERALL, DJ .

BRITISH MEDICAL JOURNAL, 1982, 284 (6322) :1081-1084

[13]

PITT CG, 1981, DEV IRON CHELATORS C, P105

[14] STUDY OF INTRACELLULAR IRON-METABOLISM USING PYRIDOXAL ISONICOTINOYL HYDRAZONE AND OTHER SYNTHETIC CHELATING-AGENTS [J].

PONKA, P ;

BOROVA, J ;

NEUWIRT, J ;

FUCHS, O ;

NECAS, E .

BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 586 (02) :278-297

[15] THE RELATIONSHIP BETWEEN LIPOPHILICITY OF HYDROXYPYRID-4-ONE IRON CHELATORS AND CELLULAR IRON MOBILIZATION, USING AN HEPATOCYTE CULTURE MODEL [J].

PORTER, JB ;

GYPARAKI, M ;

HUEHNS, ER ;

HIDER, RC .

BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (06) :1180-1180

[16] PYRIDOXAL COMPLEXES AS POTENTIAL CHELATING-AGENTS FOR ORAL-THERAPY IN TRANSFUSIONAL IRON OVERLOAD [J].

WILLIAMS, A ;

HOY, T ;

PUGH, A ;

JACOBS, A .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (11) :730-732

[17] PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR [J].

WOLFE, L ;

OLIVIERI, N ;

SALLAN, D ;

COLAN, S ;

ROSE, V ;

PROPPER, R ;

FREEDMAN, MH ;

NATHAN, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1600-1603

← 1 2 →